Modern Retina | Ophthalmology News, Events & Expert Insights
November 11th 2024. Peking University researchers have developed a deep learning-based, noninvasive choroidal angiography method that enables detailed 3D visualization of choroidal vessels from OCT scans. This technique could improve diagnostics for retinal diseases like macular degeneration, offering a safer alternative to traditional methods.
Distinction between lamellar holes and macular pseudoholes
Mar 12, 2018 · Dr. Thompson defined pseudomacular holes as a clinical diagnosis as seen via slit lamp biomicroscopy versus optical coherence tomography (OCT). “Use pseudomacular holes only to describe the biomicroscopic appearance,” he added. In contrast, a lamellar macular hole is defined by the appearance of the fovea via OCT.
ASRS 2024: FARETINA-DME Study - Modern Retina
Jul 18, 2024 · So this [FARETINA-DME] study looked at the American Academy of Ophthalmology's IRIS Registry, which is the largest specialty specific dataset in the world. There are over 540 million de-identified patient encounters. Seventy percent of all eye care encounters in the US are captured in this registry, so it is quite representative, going back to ...
SHRM characteristics impact visual acuity in wet AMD - Modern …
Aug 14, 2017 · SHRM has a detrimental effect on vision in eyes with neovascular age-related macular degeneration (nAMD), said Dr. Kumar, a vitreoretinal fellow at Cleveland Clinic, Cleveland. Investigators found that SHRM that was taller, had a layered appearance, increased reflectivity, and larger size were associated with worse visual acuity at the 12- and ...
EURETINA
EURETINA 2024: An overview of the SING-IMT implant with Alfonso Savastano, MD, PhD. Hattie Hayes; Martin David Harp. September 30th 2024. Alfonso Savastano, MD, PhD spoke about the SING-IMT implant during his interview with Ophthalmology Times Europe, which took place at the EURETINA 2024 meeting held in Barcelona, Spain, on September 19-22, 2024.
NR600 retinal prosthesis: Safe with promising visual results
Oct 2, 2020 · The NR600 is a stand-alone implant without wires that traverse the eye wall. Dr Stalmans explained that the device uses the natural eye optics and the retinal natural signal processing to provide the patient with vision. In this study, a miniature chip was implanted in the retina and held in place in the sulcus with haptics resembling those of ...
AAO 2023: Blindness and vision loss in the United States: Do …
November 4, 2023. By Hattie Hayes. David Hutton. News. Article. Conference | AAO. Mary Elizabeth Hartnett, MD, FACS, discussed the impact of blindness and vision loss on women in the United States.
FDA approves XIPERE injection for treatment of uveitic macular …
On October 25, 2021, Bausch + Lomb and Clearside Biomedical announced that the US FDA granted approval to triamcinolone acetonide injectable suspension (XIPERE) for suprachoroidal use for the treatment of macular edema associated with uveitis. Formerly known as CLS-TA, the novel product represents the first ever treatment approved by the FDA ...
AAO 2024: Cardiac arrhythmias are associated with AMD
Oct 17, 2024 · R. Theodore Smith, MD, PhD, Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, New York, reported that cardiac arrhythmias such as atrial fibrillation are associated with subretinal drusenoid deposits (SDDs) in age-related macular degeneration (AMD). The SDDs may serve as a biomarker of serious heart disease.
jCyte, Inc. announces pivotal trial of jCell for RP to start in second ...
Feb 24, 2024 · The pivotal trial of jCell to treat retinitis pigmentosa (RP) is scheduled to start enrollment during the second half of 2024. According to the company website, jCell is a first-in-class allogeneic cell therapy in late-stage clinical development for treating RP. The treatment is a minimally invasive intravitreal injection that can be performed ...